Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy (F-Sharp)
F-SHARP: A Phase I/II Trial of Focal Salvage High-dose-rate BRachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy
Sponsor: Loyola University
This NA trial investigates Locally Recurrent Prostate Cancer and is currently ongoing. Loyola University leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting NA
Status: Unknown → Active Not Recruiting · Phase: PHASE1/PHASE2 → NA
-
Sep 2024 — Oct 2025 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2024 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2024 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 6 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Jul 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2019 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2019 — Aug 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Loyola University
For direct contact, visit the study record on ClinicalTrials.gov .